Wednesday, 23 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Company
Drug
J&J AKEEGA Gets CHMP Nod for BRCA-Mutated Prostate Cancer
February 2, 2026
Company
Drug
Hengrui Ruitanning Gets NMPA Nod for Moderately Emetogenic Chemo Indication
April 21, 2026
Company
Drug
CDE Seeks Feedback on 103rd Batch of Generic Reference Preparations
February 2, 2026
Company
Deals
Kyowa Kirin Reclaims Rocatinlimab Rights from Amgen in Strategic Shift
February 2, 2026
Company
Drug
Chiesi Fabry Drug Pegunigalsidase Alfa Wins CHMP Backing for Extended Dosing
February 2, 2026
Company
Novo Nordisk Appoints Yan Cai as Greater China President Amid LeadershipChange
February 2, 2026
1
2
…
17
18
19
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?